Appendicitis Treatment Market Report 2024

The appendicitis treatment market size has grown strongly in recent years. It will grow from $3.84 billion in 2023 to $4.1 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth during the historic period can be attributed to the rising incidence of pediatric appendicitis, widespread use of antibiotics for treating the condition, an aging population, increasing sedentary lifestyles, and favorable reimbursement policies.

The appendicitis treatment market size is expected to see strong growth in the next few years. It will grow to $5.36 billion in 2028 at a compound annual growth rate (CAGR) of 6.9%. The anticipated growth during the forecast period is expected to be driven by a greater emphasis on timely diagnosis, increased research and development activities, a rising incidence of obesity, the availability of effective medications, and a growing number of ambulatory surgical centers. Key trends for this period include advancements in minimally invasive surgical techniques, enhanced diagnostic imaging technologies, the incorporation of artificial intelligence and machine learning in diagnostic decision support systems, the development of new antibiotics, and innovations in surgical stapling and suturing devices.

The increasing prevalence of lifestyle-related conditions is projected to drive growth in the appendicitis treatment market. This rise in lifestyle-related diseases is largely due to factors such as increased sedentary behavior, poor dietary habits, and elevated stress levels. These lifestyle factors, including diet and physical inactivity, may impact gut health and elevate the risk of inflammation, potentially leading to appendicitis. Diets low in fiber and high in processed foods can disrupt the digestive system and increase susceptibility to appendicitis. For example, in March 2024, the World Health Organization reported that approximately 1 in 8 people globally were affected by obesity. This includes 2.5 billion adults aged 18 and older, with 890 million living with obesity. Additionally, 37 million children under 5 and over 390 million children and adolescents aged 5-19 were overweight in 2022. Consequently, the growing prevalence of lifestyle-related conditions is fueling the growth of the appendicitis treatment market.

Key players in the appendicitis treatment market are focusing on developing advanced technologies such as artificial intelligence (AI)-integrated live-stream surgical technology to enhance surgical precision and patient outcomes. AI-integrated live-stream surgical technology involves using AI to improve surgical procedures by incorporating real-time video streaming capabilities. For instance, in April 2024, Medtronic plc, a medical device company based in Ireland, introduced new AI-driven algorithms and live streaming technology. This innovation enhances the touch surgery performance insights platform by offering detailed surgical insights and enabling secure live broadcasts of procedures. These advancements aim to improve appendicitis treatment by optimizing surgical techniques, expediting training for surgeons, and expanding access to expert guidance, leading to better outcomes and wider availability of high-quality care.

In October 2021, Sandoz Group AG, a pharmaceutical company based in Switzerland, acquired GlaxoSmithKline's cephalosporin antibiotic business for an undisclosed amount. This acquisition gives Sandoz control over three established brands - Zinnat, Zinacef, and Fortum - across more than 100 markets, thereby reinforcing its leading global position in the antibiotics sector. GlaxoSmithKline plc, a UK-based company, manufactures cephalosporin antibiotics used in treating appendicitis.

Major companies operating in the appendicitis treatment market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co Inc, AbbVie Inc., Sanofi Inc., AstraZeneca Inc, Novartis AG, Medtronic Plc, Eli Lilly and Company, Stryker Corporation, Teva Pharmaceutical Industries Ltd, Baxter International Inc, Boston Scientific Corporation, B. Braun Melsungen, Olympus Corporation, Smith & Nephew Plc, Perrigo Company, Cipla Inc., Cook Medical, Integra LifeSciences, Teligent Inc.

North America was the largest region in the appendicitis treatment market in 2023. The regions covered in the appendicitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the appendicitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Appendicitis treatment involves managing inflammation of the appendix, typically through an appendectomy - a surgical procedure to remove the inflamed appendix, usually performed urgently to prevent rupture. In some instances, antibiotics may be used to treat or manage the condition prior to or in place of surgery.

The main types of appendicitis treatment are acute and chronic appendicitis. Acute appendicitis is a sudden inflammation of the appendix, a small pouch connected to the large intestine, characterized by severe abdominal pain, nausea, and fever. It often requires immediate surgical intervention. Treatment options include surgery, laparoscopic surgery, open laparotomy, and medication, which can be administered orally or parenterally. The primary end users of these treatments are hospitals, ambulatory surgical centers, specialty clinics, and other medical facilities.

The appendicitis treatment market research report is one of a series of new reports that provides appendicitis treatment market statistics, including appendicitis treatment industry global market size, regional shares, competitors with an appendicitis treatment market share, detailed appendicitis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the appendicitis treatment industry. This appendicitis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The appendicitis treatment market consists of revenues earned by entities by providing services such as emergency medical services, diagnostic imaging, laboratory testing, postoperative care, pain management, and follow-up consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. The appendicitis treatment market also includes sales of appendectomy kits, laparoscopic surgery equipment and pain relievers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.